13th International Congress
THE "NEW FRONTIERS"
OF ARRHYTHMIAS 1998

January 24-31, 1998
Marilleva, Trento, Italy

S-166

Dual chamber pacemaker defibrillator:
clinical results

Ali Oto.
Hacettepe University School of Medicine, Ankara, Turkey

Recently published trials have confirmed that in ventricular fibrillation survivors or in patients with sustained ventricular tachycardia the implantable cardioverter defibrillators have a role to increase the survival of the patients1. However there have been some limitations in the practice of ICD: the high incidence of inappropriate ICD therapy due to supraventricular tachyarrhythmias up to 25% in some series despite improved detection algorithms has been a major challenge2. Therefore there is an obvious need to have a better detection capability for supraventricular tachyarrhythmias which has been achieved by atrial signal through atrial sensing in the new generation of ICDs.
However even the detection is better in those devices still there is another limitation in providing the pacing. Until recently implantable cardioverter defibrillators could provide only fixed rate ventricular pacing although the preservation of atrioventricular synchrony particularly in patients with sick sinus syndrome and with limited left ventricular function has been shown to reduce morbidity and even mortality3,4. This issue is important from the clinical practice point of view. According to a recent study in a series of 139 ICD patients 25 (18%) were in need of antibradycardia pacing. Based on current indications DDD pacing was indicated in 20 (80%) of them5.
Surely implantation of a dual chamber pacemaker in addition to an ICD is always an option. However such an approach potentially may create other problems. Interaction of pacemakers with already implanted devices has been repeatedly reported6-8. Moreover the addition of another device and leads are not free of trouble. Therefore an implantable device provides dual chamber pacing capability potentially of benefit both in terms of better detection algorithm for atrial signals and giving the opportunity of dual chamber pacing.

Key Words

Implantable cardioverter defibrillator – new perspectives  
dual chamber ICD, clinical results, ICD inappropriate incidences, atrial sensing-pacing, atriventricular association algorithm, French multicenter trial, VAN detection algorithms, R

 

forward

CARDIOnet® - registered trade mark name
Copyright © 1996-1998 by CARDIOnet. All rights reserved.